A phase I study of continuous oral dosing of OSI-906, a dual inhibitor of insulin-like growth factor-1 and insulin receptors, in patients with advanced solid tumors.
| Image |  |
|---|---|
| Description | scientific article published on 11 September 2014 |
| Author/s |
author: Ronit Simantov Igor Puzanov |
| Publication date | September 11, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |